Document Detail


A 6-year clinical trial of methotrexate therapy in the treatment of ectopic pregnancy.
MedLine Citation:
PMID:  9720836     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Our aim was to assess the efficiency of methotrexate therapy for unruptured ectopic pregnancy. STUDY DESIGN: From November 1990 to December 1996, 60 patients diagnosed with unruptured ectopic pregnancies were treated by the Departamento de Ginecología y Obstetricia at the Hospital Virgen Macarena of Seville. Of these, 14 patients received an intrasacular injection of 15 mg of methotrexate, 45 were given an intramuscular dose of 50 mg/m2 and only one received the drug by both routes. RESULTS: Forty-six patients (76.7%) responded successfully to treatment. Of these, 10 had been given the drug intrasacularly (10/15, 66.7%), while 36 had received the drug intramuscularly (36/46, 78.3%). Twenty patients (33.3%) had minor side effects, the most frequent being mild abdominal pain. Falling levels of leukocytes on the third day after initiation of treatment may serve as a fairly accurate criterion to predict the patient's response to the treatment. CONCLUSION: Our data support the use of methotrexate therapy as a reliable alternative to surgical intervention in the treatment of unruptured ectopic pregnancy. Intramuscular administration, without laparoscopy, appears to be the most convenient route as it is easily implemented and has comparatively few complications.
Authors:
A Jiménez-Caraballo; G Rodríguez-Donoso
Related Documents :
679086 - Interstitial pregnancy following ipsilateral salpingo-oophorectomy.
8453126 - Laparoscopic cholecystectomy in pregnancy.
16882076 - Rupture of ectopic pregnancy implanted in the bladder.
20137786 - The efficacy of multiple-dose methotrexate treatment for unruptured tubal ectopic pregn...
18472646 - A multiple marker model to predict pregnancy viability when progesterone is indeterminate.
7707856 - Prognostic indicators for in vitro fertilization success.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  79     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-10-29     Completed Date:  1998-10-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  167-71     Citation Subset:  IM    
Affiliation:
Departamento de Ginecología y Obstetricia, Hospital Universitario Virgen Macarena, Seville, Spain. ajimenezc@meditex.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / therapeutic use*
Adult
Chorionic Gonadotropin, beta Subunit, Human / blood
Female
Humans
Methotrexate / administration & dosage,  adverse effects,  therapeutic use*
Pregnancy
Pregnancy, Ectopic / drug therapy*
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Chorionic Gonadotropin, beta Subunit, Human; 59-05-2/Methotrexate
Comments/Corrections
Comment In:
Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):233   [PMID:  10206424 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of open retropubic and laparoscopic colposuspension for treatment of stress urinary incon...
Next Document:  Emotional distress following induced abortion: a study of its incidence and determinants among abort...